The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Interventional
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Efficacy in treatment of diarrhea
To evaluate the efficacy of CASAD 3 grams per day in reducing the severity of diarrhea after 1 week of treatment in patients with MTC.
1 week
No
United States: Food and Drug Administration
SAL 2012-0584
NCT01739634
November 2012
December 2013
Name | Location |
---|---|
MD Anderson Cancer Center | Houston, Texas 77030-4096 |